Research & Development at JN draws upon expertise in multiple discovery plat­forms. This means that, in addition to traditional small molecules, we are sharply focused on biologics. As a result, nearly all of our current pipeline is composed of not a bio-engineered molecules but naturally occurring pathogen epitopes to discover vaccines for infectious diseases.

 

JN-International Medical Corporation, Omaha, Nebraska, USA